Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
san francisco top stories
9
×
clinical trials
san francisco blog main
national top stories
new york top stories
boston blog main
boston top stories
fda
new york blog main
national
san diego blog main
san diego top stories
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
cancer
drugs
europe blog main
new york
roche
abaloparatide
akcea therapeutics
allergan
alnylam pharmaceuticals
What
drug
9
×
medicine
approved
fda
cancer
new
data
disease
market
marketing
patients
pharmaceuticals
aces
afternoon
ago
alnylam
alnylam’s
alzheimer's
amgen
amgen’s
announced
approval
atrophy
bad
battle
big
brain
cannabis
carries
case
ceo
cholesterol
daily
deeper
derivative
developed
dna
doses
eisai
epilepsy
Language
unset
Current search:
medicine���s
×
drug
×
" san francisco top stories "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug